Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Problem 79-5, Asymptotic Behavior of a Sequence

Autor: Erlebach, L., Ruehr, O.

Publikováno v: SIAM Review, 1979 Jan 01. 21(1), 140-140.

Externí odkaz: https://www.jstor.org/stable/2029944

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases uncovers cholesterol as a regulator of astrocyte reactivity impaired by ApoE4.

Autor: Feringa FM; Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands., Hertog SJK; Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, the Netherlands., Wang L; Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands., Derks RJE; Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands., Kruijff I; Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, the Netherlands., Erlebach L; German Center for Neurodegenerative Diseases (DZNE) Tübingen, Tübingen, Germany.; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Heijneman J; Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, the Netherlands., Miramontes R; Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.; Department of Neurobiology and Behavior, University of California, Irvine, CA, USA.; Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, USA., Pömpner N; Leibniz Institute on Aging, Fritz Lipmann Institute, Jena, Germany., Blomberg N; Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands., Olivier-Jimenez D; Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands., Johansen LE; Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands., Cammack AJ; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; UK Dementia Research Institute at UCL, University College London, London, UK., Giblin A; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; UK Dementia Research Institute at UCL, University College London, London, UK., Toomey CE; Department of Clinical and Molecular Neuroscience, Queen Square Institute of Neurology, University College London, London, UK., Rose IVL; Institute for Neurodegenerative Diseases and Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA, USA., Yuan H; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Ward M; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Isaacs AM; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; UK Dementia Research Institute at UCL, University College London, London, UK., Kampmann M; Department of Biochemistry and Biophysics, Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA., Kronenberg-Versteeg D; German Center for Neurodegenerative Diseases (DZNE) Tübingen, Tübingen, Germany.; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Lashley T; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK., Thompson LM; Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.; Department of Neurobiology and Behavior, University of California, Irvine, CA, USA.; Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, USA., Ori A; Leibniz Institute on Aging, Fritz Lipmann Institute, Jena, Germany., Mohammed Y; Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H3A 0G4, Canada., Giera M; Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands., van der Kant R; Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, the Netherlands.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 03. Date of Electronic Publication: 2024 Jul 03.